Dao TH, Echlin H, McKnight A, et al. favors tolerance via metabolic adaptation over resistance to circumvent fluoroquinolones. mBio. 2024:e0282823. doi:10.1128/mbio.02828-23.

Proctor E-J, Frost HR, Satapathy S, et al. Molecular characterisation of the interaction between human IgG and the M-related proteins from Streptococcus pyogenes. The Journal of biological chemistry. 2024:105623. doi:10.1016/j.jbc.2023.105623.

Salamzade R, McElheny CL, Manson AL, Earl AM, Shaikh N, Doi Y. Genomic epidemiology and antibiotic susceptibility profiling of uropathogenic among children in the United States. mSphere. 2023:e0018423. doi:10.1128/msphere.00184-23.

Yu C-H, Sephton-Clark P, Tenor JL, et al. Gene Expression of Diverse Cryptococcus Isolates during Infection of the Human Central Nervous System. mBio. 2021;12(6):e0231321. doi:10.1128/mBio.02313-21.

Fu MS, Liporagi-Lopes LC, Santos SRD, et al. Amoeba Predation of Cryptococcus neoformans Results in Pleiotropic Changes to Traits Associated with Virulence. mBio. 2021;12(2). doi:10.1128/mBio.00567-21.

Iyer KR, Camara K, Daniel-Ivad M, et al. An oxindole efflux inhibitor potentiates azoles and impairs virulence in the fungal pathogen Candida auris. Nat Commun. 2020;11(1):6429. doi:10.1038/s41467-020-20183-3.

Farrer RA, Ford CB, Rhodes J, et al. Transcriptional Heterogeneity of VGII Compared with Non-VGII Lineages Underpins Key Pathogenicity Pathways. mSphere. 2018;3(5). doi:10.1128/mSphere.00445-18.

Sephton-Clark PCS, Muñoz JF, Ballou ER, Cuomo CA, Voelz K. Pathways of Pathogenicity: Transcriptional Stages of Germination in the Fatal Fungal Pathogen . mSphere. 2018;3(5). doi:10.1128/mSphere.00403-18.

Shapiro RS, Chavez A, Porter CBM, et al. A CRISPR-Cas9-based gene drive platform for genetic interaction analysis in Candida albicans. Nat Microbiol. 2018;3(1):73-82. doi:10.1038/s41564-017-0043-0.

Clatworthy AE, Romano KP, Hung DT. Whole-organism phenotypic screening for anti-infectives promoting host health. Nat Chem Biol. 2018;14(4):331-341. doi:10.1038/s41589-018-0018-3.